Mirae Asset Healthcare Fund -Regular Growth
Fund House: Mirae Asset Mutual Fund| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 10-07-2018 |
| Asset Class: Equity |
| Benchmark: S&P BSE Healthcare TRI |
| Expense Ratio: 2.1% As on (31-07-2022) |
| Status: Open Ended Schemes |
| Minimum Investment: 5000.0 |
| Minimum Topup: 1000.0 |
| Total Assets: 1,722.74 Cr As on (31-08-2022) |
| Turn over: 29% | Exit Load: 1% for redemption within 365 days |
21.175
-0.23 (-1.0909%)
19.21%
S&P BSE Healthcare TRI 11.91%
PERFORMANCE
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
Investment Objective
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
Current Asset Allocation (%)
Indicators
| Volatility | |
| Sharp Ratio | 1.09 |
| Alpha | 5.64 |
| Beta | 0.95 |
| Yield to Maturity | - |
| Average Maturity | - |
PEER COMPARISON
| Scheme Name | Inception Date |
1 Year Return(%) |
2 Year Return(%) |
3 Year Return(%) |
5 Year Return(%) |
10 Year Return(%) |
|---|---|---|---|---|---|---|
| Mirae Asset Healthcare Fund -Regular Growth | 10-07-2018 | -10.56 | 11.69 | 27.19 | - | - |
| SBI Healthcare Opportunities Fund - Regular Plan -Growth | 14-07-1999 | -9.2 | 10.87 | 24.08 | 11.39 | 14.33 |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | 28-12-2015 | -10.19 | 10.28 | 21.45 | 14.48 | - |
| ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option | 05-07-2018 | -12.12 | 8.89 | 24.93 | - | - |
| Nippon India Pharma Fund-Growth Plan-Growth Option | 01-06-2004 | -12.31 | 10.72 | 23.91 | 15.87 | 15.52 |
| DSP Healthcare Fund - Regular Plan - Growth | 05-11-2018 | -12.74 | 8.96 | 26.59 | - | - |
| UTI Healthcare Fund - Regular Plan - Growth Option | 05-08-2005 | -15.06 | 7.06 | 22.16 | 11.89 | 12.53 |
| IDBI Healthcare Fund - Regular Plan - Growth | 22-02-2019 | -15.26 | 4.64 | 18.67 | - | - |
| Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | 05-07-2019 | -15.33 | 5.75 | 17.76 | - | - |
Scheme Characteristics
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Riskometer
PORTFOLIO
Market Cap Distribution
Small Cap
18.06%
Others
0.37%
Large Cap
55.29%
Mid Cap
26.3%
Scheme Documents
Tax Benefits of investing in this fund
Long term capital gains (LTCG) tax @10% (plus surcharge, if applicable and cess) without indexation if units held for more than 12 months#
Short term capital gains (STCG) tax @ 15% (plus surcharge, if applicable and cess) if units are held for less than 12 months.
Investor does not pay any tax on dividends but a Dividend Distribution Tax (DDT) is deducted at source @11.648% (10% + 12% surcharge + 4% Health & education cess) **
# Capital gain accrued up to January 31st 2018 is exempt from LTCG tax in respect of units acquired before January 31, 2018 & redeemed on or after April 1, 2018. ** The DDT is to be paid by the mutual fund
